EllaDx home
← The Journal
Fertility & cycle

Charting your cycle with data, not guesswork

Pairing basal body temperature with a four-point hormone panel.

EllaDx Team·Feb 18, 2026·7 min read

Basal body temperature charting tells you that ovulation happened - after the fact. LH strips tell you a surge occurred - which may or may not result in ovulation. A timed hormone panel tells you whether the hormonal infrastructure for fertility actually performed. Used together, they remove almost all ambiguity from a single cycle.

Fertility awareness methods have been around for a century. What's changed is the ability to pair behavioural data - waking temperature, LH strips, cervical mucus observations - with a blood panel timed to the same cycle. The combination is what closes the loop.

What each tool actually confirms

Basal body temperature (BBT)

After ovulation, progesterone raises your resting body temperature by 0.2–0.5°C. This is the sustained thermal shift you're looking for on a BBT chart - a plateau that holds for 12–14 days until your period. BBT confirms ovulation happened. It doesn't confirm when, doesn't confirm adequate progesterone, and can be disrupted by illness, alcohol, or inconsistent wake times.

LH strips

A positive LH test signals a surge - typically 24–36 hours before ovulation. But an LH surge doesn't guarantee ovulation follows. Luteinised unruptured follicle syndrome (LUF) produces a surge without egg release, more common in women with endometriosis. LH strips are excellent for timing intercourse or insemination; they are not ovulation confirmation.

The hormone panel

Blood confirms what the other tools can only suggest. Progesterone above 10 ng/mL at day 21 (or 7 days post-LH surge) confirms ovulation and adequate corpus luteum function. Estradiol in the luteal phase characterises the estrogen environment. Together they give you the hormonal reality behind the behavioural chart.

The two draws worth knowing

Day 3 draw (follicular baseline)

  • FSH - ovarian reserve signal; elevated FSH (>10 IU/L) suggests diminished reserve.
  • LH - baseline LH; elevated at baseline in PCOS.
  • Estradiol - elevated day-3 estradiol (>80 pg/mL) can falsely suppress FSH, masking poor reserve.
  • AMH - cycle-independent; can be drawn any day but commonly batched here.

Day 21 draw (7 days post-ovulation)

  • Progesterone - the ovulation confirmation. >10 ng/mL: strong ovulation. 3–10 ng/mL: weak luteal phase. <3 ng/mL: likely anovulation.
  • Estradiol - in ratio with progesterone; high estradiol relative to low progesterone is the estrogen dominance pattern.

Building a picture over time

A single cycle snapshot is informative. Two cycles give you reproducibility. Three give you a pattern. The most common finding across multiple cycles isn't dramatic - it's mild progesterone insufficiency that's consistent, cycle after cycle, explaining subtler symptoms: PMS that builds across the luteal phase, light sleep the week before menstruation, or a sense of emotional fragility that tracks perfectly with the chart.

Paired data makes the conversation with a clinician much more productive. Instead of 'my cycles feel off,' you arrive with: 'My LH surge is on day 16, BBT rises on day 17, but day-21 progesterone has been 6–7 ng/mL for three cycles.' That is a clinical finding. That gets taken seriously.

Sources

Peer-reviewed citations behind this piece.

  1. [1]
    Stricker R, Eberhart R, Chevailler MC, et al. Establishment of detailed reference values for luteinizing hormone, follicle stimulating hormone, estradiol, and progesterone during different phases of the menstrual cycle.
    Clin Chem Lab Med, 2006; 44(7): 883–887
  2. [2]
    Practice Committee of the American Society for Reproductive Medicine. Testing and interpreting measures of ovarian reserve: a committee opinion.
    Fertil Steril, 2020; 114(6): 1151–1157
  3. [3]
    Baird DT, Collins J, Egozcue J, et al. Fertility and ageing.
    Hum Reprod Update, 2005; 11(3): 261–276
  4. [4]
    Prior JC. Progesterone as a bone-trophic hormone.
    Endocr Rev, 1990; 11(2): 386–398
Keep reading

More in Fertility & cycle.

The Journal

One long read, every Tuesday.

Women-first, research-backed, no sponsorship angles. Unsubscribe in one click.